SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-033184
Filing Date
2020-12-09
Accepted
2020-12-09 17:35:11
Documents
1
Period of Report
2020-12-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 19646
  Complete submission text file 0000899243-20-033184.txt   25540
Mailing Address ATHYRIUM CAPITAL MANAGEMENT, LP 505 FIFTH AVENUE, FL 18 NEW YORK NY 10017
Business Address
Ferrell Jeffrey (Reporting) CIK: 0001394967 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39334 | Film No.: 201378762

Mailing Address 325 N. SAINT PAUL STREET SUITE 4900 DALLAS TX 75201
Business Address 325 N. SAINT PAUL STREET SUITE 4900 DALLAS TX 75201 212-476-9000
NB Alternatives Advisers LLC (Reporting) CIK: 0001469000 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39334 | Film No.: 201378768

Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
PROGENITY, INC. (Issuer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017
Business Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017 212-402-6925
Athyrium Capital Management, LP (Reporting) CIK: 0001728001 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39334 | Film No.: 201378761

Mailing Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017
Business Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017 646-434-1636
Athyrium Capital Holdings, LLC (Reporting) CIK: 0001815216 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39334 | Film No.: 201378763

Mailing Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017
Business Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017 646-434-1636
Athyrium Funds GP Holdings LLC (Reporting) CIK: 0001815225 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39334 | Film No.: 201378764

Mailing Address 325 N. SAINT PAUL STREET, SUITE 4900 DALLAS TX 75201
Business Address 325 N. SAINT PAUL STREET, SUITE 4900 DALLAS TX 75201 212-476-5781
NB Alternatives GP Holdings LLC (Reporting) CIK: 0001815407 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39334 | Film No.: 201378769

Mailing Address 1209 AVENUE OF THE AMERICAS NEW YORK NY 10104
Business Address 1209 AVENUE OF THE AMERICAS NEW YORK NY 10104 212-476-5781
Athyrium Opportunities Advisers LLC (Reporting) CIK: 0001815484 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39334 | Film No.: 201378766

Mailing Address 1290 AVENUE OF THE AMERICAS NEW YORK NY 10104
Business Address 1290 AVENUE OF THE AMERICAS NEW YORK NY 10104 212-476-5781
NB Alternatives Holdings LLC (Reporting) CIK: 0001815501 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39334 | Film No.: 201378765

Mailing Address 505 FIFTH AVENUE, 18TH FLOOR NEW YORK NY 10017
Business Address 505 FIFTH AVENUE, 18TH FLOOR NEW YORK NY 10017 646-434-1636
Athyrium Opportunities III Acquisition LP (Reporting) CIK: 0001835266 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39334 | Film No.: 201378767